2016
DOI: 10.3402/fnr.v60.32963
|View full text |Cite
|
Sign up to set email alerts
|

Effects of royal jelly supplementation on regulatory T cells in children with SLE

Abstract: Background and objectiveTo our knowledge, no previous studies have focused on the immunomodulatory effects of fresh royal jelly (RJ) administration on systemic lupus erythematosus (SLE) in humans. Our aim was to study the effect of fresh RJ administration on the disease course in children with SLE with some immunological markers (CD4+ and CD8+ regulatory T cells and T lymphocytes apoptosis).MethodsThis was an open-label study in which 20 SLE children received 2 g of freshly prepared RJ daily, for 12 weeks.Resu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 33 publications
1
22
0
Order By: Relevance
“…Moreover, CD8 + CD25 +high and CD8 + CD25 +high FOXP3 + cells (CD8 + Treg cells) significantly increased after royal jelly treatment ( p < 0.01). Percentages of CD8 + CD25 +high and CD8 + Treg cells in patients with SLE at baseline (prior to royal jelly treatment) were significantly lower than in the control group of children without SLE ( p = 0.003) ( 197 ).…”
Section: Nutraceuticsmentioning
confidence: 97%
“…Moreover, CD8 + CD25 +high and CD8 + CD25 +high FOXP3 + cells (CD8 + Treg cells) significantly increased after royal jelly treatment ( p < 0.01). Percentages of CD8 + CD25 +high and CD8 + Treg cells in patients with SLE at baseline (prior to royal jelly treatment) were significantly lower than in the control group of children without SLE ( p = 0.003) ( 197 ).…”
Section: Nutraceuticsmentioning
confidence: 97%
“…Immunomodulatory response plays a significant role in allergy, cancer, and inflammation by activation of antibody formation or inhibition of white blood cell activities [132]. The first human study in systemic lupus erythematosus (SLE) in children reveals that the effect of RJ treatment in SLE indicates a significant improvement after three months of administration [133]. The anti-allergic factors of RJ inhibit interleukin-4 (IL-4) production which is induced by anti-CD3 activated spleen cells derived from ovalbumin (OVA)/alum-immunized mice.…”
Section: Immunomodulatory Activitymentioning
confidence: 99%
“…RJ significantly delayed emerging of symptoms, decreased proteinuria, and reduced anti-dsDNA antibody, anti-ssDNA antibody, anti-erythrocyte antibody and splenic autoreactive B cells. In another study on pediatric SLE Ortadoğu Tıp Dergisi / Ortadogu Medical Journal patients, three-month RJ consumption resulted with a particular increase in CD4+ regulatory T cell levels and decrease in apoptotic CD4+ T cell cell levels [65]. Erem et al [66] studied T cell culture for potential effects of RJ on healthy human and patients with Graves disease.…”
Section: Immunologic Activitiesmentioning
confidence: 99%